| 23S rRNA | 23S ribosomal RNA |
| ACG | American College of Gastroenterology |
| AMX | amoxicillin |
| Bi | bismuth |
| CENTRAL | Cochrane Central Register of Controlled Trials |
| CI | confidence interval |
| CLA | clarithromycin |
| CLA-R | clarithromycin-resistant |
| CYP2C19 | cytochrome P450 2C19 |
| ESO | esomeprazole |
| H. pylori | Helicobacter pylori |
| Hp-EuReg | European Registry on Helicobacter pylori Management |
| KPZ | keverprazan |
| LAN | lansoprazole |
| MeSH | Medical Subject Headings |
| MIC | minimum inhibitory concentration |
| MTZ | metronidazole |
| NR | not reported |
| OME | omeprazole |
| P-CAB | potassium-competitive acid blocker |
| PICO | population, intervention, comparator, and outcome |
| PPI | proton pump inhibitor |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROSPERO | International Prospective Register of Systematic Reviews |
| RAB | rabeprazole |
| RCT | randomized controlled trial |
| RoB 2 | revised Cochrane risk-of-bias tool for randomized trials |
| RR | risk ratio |
| RT-PCR | real-time polymerase chain reaction |
| TPZ | tegoprazan |
| VPZ | vonoprazan |